JP2026041958A5 - - Google Patents

Info

Publication number
JP2026041958A5
JP2026041958A5 JP2025244095A JP2025244095A JP2026041958A5 JP 2026041958 A5 JP2026041958 A5 JP 2026041958A5 JP 2025244095 A JP2025244095 A JP 2025244095A JP 2025244095 A JP2025244095 A JP 2025244095A JP 2026041958 A5 JP2026041958 A5 JP 2026041958A5
Authority
JP
Japan
Prior art keywords
subject
therapeutic agent
lyso
asmd
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025244095A
Other languages
English (en)
Japanese (ja)
Other versions
JP2026041958A (ja
Filing date
Publication date
Priority claimed from JP2018236856A external-priority patent/JP6835806B2/ja
Application filed filed Critical
Publication of JP2026041958A publication Critical patent/JP2026041958A/ja
Publication of JP2026041958A5 publication Critical patent/JP2026041958A5/ja
Pending legal-status Critical Current

Links

JP2025244095A 2013-06-07 2025-12-10 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用 Pending JP2026041958A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361832302P 2013-06-07 2013-06-07
US61/832,302 2013-06-07
JP2018236856A JP6835806B2 (ja) 2013-06-07 2018-12-19 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用
JP2021015390A JP7414750B2 (ja) 2013-06-07 2021-02-03 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用
JP2023220385A JP7830414B2 (ja) 2013-06-07 2023-12-27 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023220385A Division JP7830414B2 (ja) 2013-06-07 2023-12-27 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用

Publications (2)

Publication Number Publication Date
JP2026041958A JP2026041958A (ja) 2026-03-10
JP2026041958A5 true JP2026041958A5 (https=) 2026-03-18

Family

ID=51062988

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2016518053A Active JP6457501B2 (ja) 2013-06-07 2014-06-06 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用
JP2018236856A Active JP6835806B2 (ja) 2013-06-07 2018-12-19 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用
JP2021015390A Active JP7414750B2 (ja) 2013-06-07 2021-02-03 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用
JP2023220385A Active JP7830414B2 (ja) 2013-06-07 2023-12-27 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用
JP2025244095A Pending JP2026041958A (ja) 2013-06-07 2025-12-10 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用

Family Applications Before (4)

Application Number Title Priority Date Filing Date
JP2016518053A Active JP6457501B2 (ja) 2013-06-07 2014-06-06 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用
JP2018236856A Active JP6835806B2 (ja) 2013-06-07 2018-12-19 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用
JP2021015390A Active JP7414750B2 (ja) 2013-06-07 2021-02-03 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用
JP2023220385A Active JP7830414B2 (ja) 2013-06-07 2023-12-27 酸性スフィンゴミエリナーゼ障害のマーカーおよびその使用

Country Status (29)

Country Link
US (4) US10022428B2 (https=)
EP (2) EP3584580A1 (https=)
JP (5) JP6457501B2 (https=)
KR (3) KR102292298B1 (https=)
CN (2) CN105474017A (https=)
AU (5) AU2014274670B2 (https=)
CA (1) CA2914751C (https=)
CL (1) CL2015003563A1 (https=)
CR (1) CR20150638A (https=)
DK (1) DK3004896T3 (https=)
EA (1) EA035342B1 (https=)
ES (1) ES2762608T3 (https=)
HR (1) HRP20192246T1 (https=)
HU (1) HUE047863T2 (https=)
IL (3) IL298675B2 (https=)
LT (1) LT3004896T (https=)
MA (1) MA38638B1 (https=)
MX (1) MX370570B (https=)
MY (1) MY185990A (https=)
NZ (1) NZ754328A (https=)
PH (1) PH12015502687A1 (https=)
PL (1) PL3004896T3 (https=)
PT (1) PT3004896T (https=)
RS (1) RS59677B1 (https=)
SG (2) SG11201509622WA (https=)
SI (1) SI3004896T1 (https=)
UA (1) UA120591C2 (https=)
WO (1) WO2014197859A1 (https=)
ZA (1) ZA201508630B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3998078T1 (sl) * 2009-08-28 2026-02-27 Genzyme Corporation Encimsko nadomestno zdravljenje z naraščajočim odmerkom za zdravljenje pomanjkanja kisle sfingomielinaze
ES2762608T3 (es) * 2013-06-07 2020-05-25 Genzyme Corp Marcador para trastornos de esfingomielinasa ácida y usos del mismo
JP6984854B2 (ja) * 2015-10-08 2021-12-22 国立大学法人千葉大学 ニーマン・ピック病c型を予防または治療するための医薬組成物
KR20250025051A (ko) 2017-08-24 2025-02-20 사노피 산성 스핑고미엘린분해효소 결핍증 환자에서의 비정상적 골병태의 치료
CR20200129A (es) 2017-10-02 2020-08-22 Denali Therapeutics Inc Proteínas de fusión que comprenden enzimas de terapia de reemplazo de enzimas
HUE071194T2 (hu) * 2019-05-31 2025-08-28 Genzyme Corp Kétdimenziós LC-MS/MS rendszerek
WO2024026390A2 (en) * 2022-07-28 2024-02-01 Wylder Nation Foundation Compositions and methods for diagnosing, treating, and preventing lysosomal storage diseases

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4082781A (en) 1976-06-04 1978-04-04 The United States Of America As Represented By The Department Of Health, Education And Welfare Synthesis of 2-alkanoylamino-4-nitrophenyl phosphorylcholine-hydroxide
US4039388A (en) 1976-06-04 1977-08-02 The United States Of America As Represented By The Government Diagnostic test for Niemann-Pick disease
US5773278A (en) 1991-05-03 1998-06-30 Mount Sinai Medical Center Acid sphingomyelinase gene
AR034413A1 (es) 2000-08-25 2004-02-25 Nestor Abel Chamoles Metodo para determinar la actividad de las enzimas lisosomales
US7001994B2 (en) 2001-01-18 2006-02-21 Genzyme Corporation Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins
US7615224B2 (en) 2004-12-02 2009-11-10 Women's And Children's Hospital Multiplex-bead complex for determination of lysosomal storage disorders
JP2006214731A (ja) * 2005-02-01 2006-08-17 Institute Of Physical & Chemical Research スフィンゴミエリンの検出方法
WO2007078806A2 (en) 2005-12-15 2007-07-12 The Research Foundation Of State University Of New York Enzymatic methods for measuring plasma and tissue sphingomylelin and phosphatidylcholine
AR059089A1 (es) 2006-01-20 2008-03-12 Genzyme Corp Administracion intraventricular de una enzima para enfermedades de almacenamiento lisosomal
US8026099B2 (en) 2007-07-26 2011-09-27 Washington University Lipid profile as a biomarker for early detection of neurological disorders
US8497122B2 (en) 2008-04-11 2013-07-30 Washington University Biomarkers for Niemann-pick C disease and related disorders
SI3998078T1 (sl) * 2009-08-28 2026-02-27 Genzyme Corporation Encimsko nadomestno zdravljenje z naraščajočim odmerkom za zdravljenje pomanjkanja kisle sfingomielinaze
JP2013002933A (ja) 2011-06-16 2013-01-07 Hitachi Plant Technologies Ltd 3次元測位システム
BR112014009223B1 (pt) * 2011-11-15 2021-04-06 Centogene Gmbh Métodos para o diagnóstico da doença de niemann-pick, método para determinação do curso da doença de niemann-pick, método para determinação da eficácia de pelo menos um tratamento, uso de análise espectrométrica de massa e kit
JP6660291B2 (ja) * 2013-05-14 2020-03-11 セントジーン アーゲー ニーマン・ピック病の診断のための方法
ES2762608T3 (es) 2013-06-07 2020-05-25 Genzyme Corp Marcador para trastornos de esfingomielinasa ácida y usos del mismo

Similar Documents

Publication Publication Date Title
JP2026041958A5 (https=)
KR102766876B1 (ko) 타우로데옥시콜린산 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 코로나바이러스감염증-19(covid-19) 치료용 조성물
KR20170128633A (ko) 탈수초성 질환 및 다른 신경계 질환을 앓는 환자에서 신경-인지 및/또는 신경-정신 손상을 개선하기 위한 4-아미노피리딘의 용도
JP2016526050A5 (https=)
El Messaoudi et al. Impact of metformin on endothelial ischemia-reperfusion injury in humans in vivo: a prospective randomized open, blinded-endpoint study
JP2017536403A5 (https=)
CN115397431A (zh) 用于治疗涉及全身过度炎症反应的病症的eclitasertib
Yokoyama et al. Low-dose sirolimus for a patient with blue rubber bleb nevus syndrome
JP2022546550A5 (https=)
JP7490654B2 (ja) 持続的腎代替療法における経皮的糸球体濾過量測定の使用
CN1090491A (zh) 预防及治疗脓毒症的方法
CN116171151A (zh) 用于治疗病毒感染的pde3抑制剂
RU2739212C1 (ru) Препарат для комплексной терапии заболеваний, вызванных бета-коронавирусами
Zhang et al. Recovery of a 91-year-old COVID-19 Patient with Medical and Psychological Support
RU2227034C2 (ru) Способ лечения саркоидоза
Maleki et al. The COVID-19 Infection Complicated with Chylopericardium in a Six-Month-Old Boy After Glenn Shunt Surgery; A Rare Phenomenon in the Pediatric
Massarella et al. Effect of congestive heart failure on the pharmacokinetics of cibenzoline
Zar et al. Oral trimethoprim-sulphamethoxazole levels in stable HIV-infected children
JP2002114672A (ja) C型又は非b非c型肝炎ウイルスによる肝機能異常の改善剤
Wang et al. Effects of Food on the Pharmacokinetics and Bioequivalence of Oseltamivir Phosphate for Suspension and TAMIFLU® in Healthy Chinese Subjects: A randomized, open-label Clinical Trial.
Thomaidis et al. Immunoadsorption with tryptophan columns: a therapeutic option for the treatment of rheumatoid arthritis with septic complications
TW202606762A (zh) 治療t細胞淋巴瘤之組合物及方法
Revishvili et al. Dynamics of pulmonary injury and extracorporeal methods of hemocorrection in patients with Sars-CoV-2
Gao et al. Study on the Nursing Efficacy of Clopidogrel Combined With Oxiracetam in the Treatment of Patients with Cerebral Infarction.
WO2008144916A1 (en) Method of reducing side effects of isoniazid